News & Media
Free ASAM Treatment of Opioid Use Disorder Training
As part of the Michigan State Medical Society’s (MSMS) work through the Connecting Treatment Courts and Health Professionals initiative, MSMS and the American Society of Addiction Medicine (ASAM) have partnered to provide The ASAM Treatment of Opioid Use Disorder Course at no charge. Interested participants can register for the September 17th course.
Although the waiver training is no longer required for those practitioners intending to prescribe under the 30-patient limit without subsequent increases in the cap, the ASAM Treatment of Opioid Use Disorder Course provides all prescribers with critical information. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver, which is required for practitioners who wish to increase their 30-patient limit after the first year or who may qualify for treating up to 100 patients in the first year. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.
The following information is provided from the SAMHSA website:
“To receive a practitioner waiver to administer, dispense, and prescribe buprenorphine practitioners must notify SAMHSA’s Center for Substance Abuse Treatment (CSAT), Division of Pharmacologic Therapies (DPT) of their intent to practice this form of medication-assisted treatment (MAT). The notification of intent (NOI) must be submitted to SAMHSA before the initial dispensing or prescribing of OUD treatment medication.
Qualified practitioners include physicians, Nurse Practitioners (NPs), Physician Assistants (PAs), Clinical Nurse Specialists (CNSs), Certified Registered Nurse Anesthetist (CRNAs), and Certified Nurse-Midwifes (CNMs).
Recent Practice Guidelines have allowed for an alternative NOI for those seeking to treat up to 30 patients: The customary NOI requires eligible providers to undertake required training activities prior to their application to prescribe Buprenorphine; the alternative type of NOI allows those providers who wish to treat up to 30 patients to forego the training requirement, as well as certification to counseling and other ancillary services (i.e., psychosocial services). Practitioners utilizing this training exemption are limited to treating no more than 30 patients at any one time (time spent practicing under this exemption will not qualify the practitioner for a higher patient limit) [emphasis added]. This exemption applies only to the prescription of Schedule III, IV, and V drugs or combinations of such drugs, covered under the CSA, such as buprenorphine.
Qualified practitioners who undertake required training can treat up to 100 patients using buprenorphine for the treatment of opioid use disorder (OUD) in the first year if they possess a waiver under 21 U.S.C. § 823(g)(2) (i.e., a DATA 2000 waiver) and meet certain conditions.”